Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 OMKAR PHARMACHEM   MYLAN
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-23
MYLAN
Dec-18
OMKAR PHARMACHEM/
MYLAN
5-Yr Chart
Click to enlarge
High Rs253,967-   
Low Rs192,184-   
Sales per share (Unadj.) Rs0.51,825.4-  
Earnings per share (Unadj.) Rs0.249.6-  
Cash flow per share (Unadj.) Rs0.2391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs9.01,974.7-  
Shares outstanding (eoy) m10.08514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x41.41.7 2,458.2%   
Avg P/E ratio x113.162.0 182.3%  
P/CF ratio (eoy) x111.57.9 1,419.4%  
Price / Book Value ratio x2.51.6 158.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m2241,582,214 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m10-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m5939,158 0.0%  
Other income Rs m00-   
Total revenues Rs m5939,158 0.0%   
Gross profit Rs m3243,019 0.0%  
Depreciation Rs m0175,847 0.0%   
Interest Rs m045,170 0.0%   
Profit before tax Rs m322,002 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1-3,500 -0.0%   
Profit after tax Rs m225,502 0.0%  
Gross profit margin %57.625.9 222.6%  
Effective tax rate %25.2-15.9 -158.2%   
Net profit margin %36.62.7 1,349.0%  
BALANCE SHEET DATA
Current assets Rs m3524,425 0.0%   
Current liabilities Rs m7382,364 0.0%   
Net working cap to sales %-78.515.1 -519.1%  
Current ratio x0.41.4 27.8%  
Inventory Days Days6,28684 7,522.4%  
Debtors Days Days87693 938.8%  
Net fixed assets Rs m93182,181 0.1%   
Share capital Rs m101500 20.2%   
"Free" reserves Rs m-100-   
Net worth Rs m901,015,998 0.0%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m962,725,301 0.0%  
Interest coverage x6.61.5 445.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.10.3 16.4%   
Return on assets %2.62.6 98.6%  
Return on equity %2.22.5 87.1%  
Return on capital %3.43.2 108.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m3195,157 0.0%  
From Investments Rs mNA-100,875 -0.0%  
From Financial Activity Rs m-4-90,916 0.0%  
Net Cashflow Rs m-11,617 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare OMKAR PHARMACHEM With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare OMKAR PHARMACHEM With: AJANTA PHARMA  SUVEN PHARMACEUTICALS  PIRAMAL PHARMA  SEQUENT SCIENTIFIC  BIOFIL CHEMICALS  



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.